The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Kynurenine Pathway Metabolites in Humans: Disease and Healthy States
Open accessAbstract
Tryptophan is an essential amino acid that can be metabolised through different pathways, a major route being the kynurenine pathway. The first enzyme of the pathway, indoleamine-2,3-dioxygenase, is strongly stimulated by inflammatory molecules, particularly interferon gamma. Thus, the kynurenine pathway is often systematically up-regulated when the immune response is activated. The biological significance is that 1) the depletion of tryptophan and generation of kynurenines play a key modulatory role in the immune response; and 2) some of the kynurenines, such as quinolinic acid, 3-hydroxykynurenine and kynurenic acid, are neuroactive. The kynurenine pathway has been demonstrated to be involved in many diseases and disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, AIDS dementia complex, malaria, cancer, depression and schizophrenia, where imbalances in tryptophan and kynurenines have been found. This review compiles most of these studies and provides an overview of how the kynurenine pathway might be contributing to disease development, and the concentrations of tryptophan and kynurenines in the serum, cerebrospinal fluid and brain tissues in control and patient subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Role of nitric oxide synthesis in macrophage antimicrobial activity
Nathan, C. F., & Hibbs, J. B. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90079-g · Cited by 1,523
Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., & Mellor, A. L. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.013 · Cited by 1,272
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Coupling endoplasmic reticulum stress to the cell death program
Rao, R. V., Ellerby, H. M., & Bredesen, D. E. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401378 · Cited by 1,209
UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Wang, H., Metz, C., Miller, E. J., et al. (2004) · Nature Medicine · doi:10.1038/nm1124 · Cited by 1,170
Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin
Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y.-C. E., Mathison, J., Ulevitch, R., & Cerami, A. (1985) · Nature · doi:10.1038/316552a0 · Cited by 1,131
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
T cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Terness, P., Bauer, T. M., Röse, L., Dufter, C., Watzlik, A., Simon, H., & Opelz, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020052 · Cited by 937
The macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931
Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Pfefferkorn, E. R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.908 · Cited by 854
Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751
Yang, Y., Hentati, A., Deng, H.-X., Dabbagh, O., Sasaki, T., Hirano, M., Hung, W.-Y., Ouahchi, K., Yan, J., Azim, A. C., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-160 · Cited by 743
ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
Bi, M., Naczki, C., Koritzinsky, M., Fels, D., Blais, J., Hu, N., Harding, H., Novoa, I., Varia, M., Raleigh, J., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600777 · Cited by 729
HEYES, M. P., SAITO, K., CROWLEY, J. S., DAVIS, L. E., DEMITRACK, M. A., DER, M., DILLING, L. A., ELIA, J., KRUESI, M. J. P., LACKNER, A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 680
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
Mellor, A. L., & Munn, D. H. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01520-0 · Cited by 648
Increased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
Heyes, M. P., Brew, B. J., Martin, A., Price, R. W., Salazar, A. M., Sidtis, J. J., Yergey, J. A., Mouradian, M. M., Sadler, A. E., Keilp, J., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410290215 · Cited by 571
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Self-citationKynurenine pathway in major depression: Evidence of impaired neuroprotection
Myint, A.-M., Kim, Y. K., Verkerk, R., Scharpé, S., Steinbusch, H., & Leonard, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.013 · Cited by 527
Tryptophan metabolism in the central nervous system: medical implications
Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A. W., & Lowry, C. A. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000068 · Cited by 519
Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497
Self-citationDepression and Chronic Medical Illness
Sachdeva, S., Cohen, D., Singh, A. K., Kaul, P., & Schwartz, T. L. (2009) · Medical Psychiatry · doi:10.3109/9781420084887.012 · Cited by 496
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L. H., & Engberg, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02242-x · Cited by 471
Metz, R., DuHadaway, J. B., Kamasani, U., Laury-Kleintop, L., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1872 · Cited by 467
Human macrophages convert l-tryptophan into the neurotoxin quinolinic acid
Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 447
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Ball, H. J., Sanchez-Perez, A., Weiser, S., Austin, C. J. D., Astelbauer, F., Miu, J., McQuillan, J. A., Stocker, R., Jermiin, L. S., & Hunt, N. H. (2007) · Gene · doi:10.1016/j.gene.2007.04.010 · Cited by 434
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division
Lee, G. K., Park, H. J., Macleod, M., Chandler, P., Munn, D. H., & Mellor, A. L. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01526.x · Cited by 432
Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite
Platten, M., Ho, P. P., Youssef, S., Fontoura, P., Garren, H., Hur, E. M., Gupta, R., Lee, L. Y., Kidd, B. A., Robinson, W. H., et al. (2005) · Science · doi:10.1126/science.1117634 · Cited by 425
Depression and chronic medical illness.
Katon, W., & Sullivan, M. D. (1990) · PubMed · Cited by 383
Depression in multiple sclerosis
Minden, S. L., Orav, J., & Reich, P. (1987) · General Hospital Psychiatry · doi:10.1016/0163-8343(87)90052-1 · Cited by 382
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
O’Connor, P. W., Li, D., Freedman, M. S., Bar-Or, A., Rice, G. P. A., Confavreux, C., Paty, D. W., Stewart, J. A., & Scheyer, R. (2006) · Neurology · doi:10.1212/01.wnl.0000203121.04509.31 · Cited by 358
Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism
Takikawa, O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.032 · Cited by 337
Christen, S., Peterhans, E., & Stocker, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2506 · Cited by 334
Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus
Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., & Cullen, K. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00655.x · Cited by 330
Self-citationCharacterization of the Kynurenine Pathway in Human Neurons
Guillemin, G. J., Cullen, K. M., Lim, C. K., Smythe, G. A., Garner, B., Kapoor, V., Takikawa, O., & Brew, B. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4101-07.2007 · Cited by 324
Self-citationBeal, M. F., Matson, W. R., Swartz, K. J., Gamache, P. H., & Bird, E. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb03143.x · Cited by 311
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
Stoy, N., Mackay, G. M., Forrest, C. M., Christofides, J., Egerton, M., Stone, T. W., & Darlington, L. G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03070.x · Cited by 310
Maes, M., Scharpé, S., Meltzer, H. Y., Okayli, G., Bosmans, E., D'Hondt, P., Vanden Bossche, B., & Cosyns, P. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90003-5 · Cited by 302
The eIF‐2α kinases and the control of protein synthesis 1
De Haro, C., Méndez, R., & Santoyo, J. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.12.8903508 · Cited by 295
Tryptophan degradation and immune activation in Alzheimer's disease
Widner, B., Leblhuber, F., Walli, J., Tilz, G. P., Demel, U., & Fuchs, D. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050029 · Cited by 286
Presence of Kynurenic Acid in the Mammalian Brain
Moroni, F., Russi, P., Lombardi, G., Beni, M., & Carlà, V. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04852.x · Cited by 278
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation.
Riedel, W. J., Klaassen, T., Deutz, N. E. P., van Someren, A., & van Praag, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050845 · Cited by 271
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid
HEYES, M. P., ACHIM, C. L., WILEY, C. A., MAJOR, E. O., SAITO, K., & MARKEY, S. P. (1996) · Biochemical Journal · doi:10.1042/bj3200595 · Cited by 260
Serotonin and Human Cognitive Performance
Schmitt, J., Wingen, M., Ramaekers, J., Evers, E., & Riedel, W. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698909 · Cited by 259
Presynaptic kynurenate‐sensitive receptors inhibit glutamate release
Carpenedo, R., Pittaluga, A., Cozzi, A., Attucci, S., Galli, A., Raiteri, M., & Moroni, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01592.x · Cited by 254
Huang, A., Fuchs, D., Widner, B., Glover, C., Henderson, D. C., & Allen-Mersh, T. G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600336 · Cited by 241
Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia
Nilsson, L. K., Linderholm, K. R., Engberg, G., Paulson, L., Blennow, K., Lindström, L. H., Nordin, C., Karanti, A., Persson, P., & Erhardt, S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.013 · Cited by 238
Effects of Micronutrient Intake on Survival in Human Immunodeficiency Virus Type 1 Infection
Tang, A. M., Graham, N. M. H., & Saah, A. J. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008712 · Cited by 234
Expression of The Kynurenine Pathway Enzymes in Human Microglia and Macrophages
Guillemin, G. J., Smith, D. G., Smythe, G. A., Armati, P. J., & Brew, G. J. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_12 · Cited by 229
Self-citationTreatment with laquinimod reduces development of active MRI lesions in relapsing MS
Polman, C., Barkhof, F., Sandberg-Wollheim, M., Linde, A., Nordle, O., & Nederman, T. (2005) · Neurology · doi:10.1212/01.wnl.0000154520.48391.69 · Cited by 227
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex
Flint Beal, M., Matson, W. R., Storey, E., Milbury, P., Ryan, E. A., Ogawa, T., & Bird, E. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90191-m · Cited by 218
SUZAWA, H., Shinji, K., Arai, N., & Koda, A. (1992) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)32429-1 · Cited by 214
Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types
HEYES, M. P., CHEN, C. Y., MAJOR, E. O., & SAITO, K. (1997) · Biochemical Journal · doi:10.1042/bj3260351 · Cited by 214
Fujigaki, S., Saito, K., Sekikawa, K., Tone, S., Takikawa, O., Fujii, H., Wada, H., Noma, A., & Seishima, M. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2313::aid-immu2313>3.0.co;2-s · Cited by 213
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease
Guillemin, G. J., & Brew, B. J. (2002) · Redox Report · doi:10.1179/135100002125000550 · Cited by 212
Self-citationGoldstein, L. E., Leopold, M. C., Huang, X., Atwood, C. S., Saunders, A. J., Hartshorn, M., Lim, J. T., Faget, K. Y., Muffat, J. A., Scarpa, R. C., et al. (2000) · Biochemistry · doi:10.1021/bi992997s · Cited by 211
T Cell Apoptosis by Kynurenines
Fallarino, F., Grohmann, U., Vacca, C., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_21 · Cited by 204
Neutral amino acid transport at the human blood-brain barrier.
Hargreaves, K. M., & Pardridge, W. M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77645-5 · Cited by 199
SUZAWA, H., Kikuchi, S., Arai, N., & Koda, A. (1992) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.60.91 · Cited by 199
Williamson, R. A., Yea, C. M., Robson, P. A., Curnock, A. P., Gadher, S., Hambleton, A. B., Woodward, K., Bruneau, J.-M., Hambleton, P., Moss, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22467 · Cited by 192
Characteristics of interferon induced tryptophan metabolism in human cells in vitro
Werner-Felmayer, G., Werner, E. R., Fuchs, D., Hausen, A., Reibnegger, G., & Wachter, H. (1989) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(89)90087-6 · Cited by 190
Yasui, H., Takai, K., Yoshida, R., & Hayaishi, O. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6622 · Cited by 190
Immune activation and degradation of tryptophan in coronary heart disease
Wirleitner, B., Rudzite, V., Neurauter, G., Murr, C., Kalnins, U., Erglis, A., Trusinskis, K., & Fuchs, D. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01186.x · Cited by 190
Identification of quinolinic acid in rat and human brain tissue
Wolfensberger, M., Amsler, U., Cuénod, M., Foster, A. C., Whetsell, W. O., & Schwarcz, R. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90458-5 · Cited by 185
Belladonna, M. L., Grohmann, U., Guidetti, P., Volpi, C., Bianchi, R., Fioretti, M. C., Schwarcz, R., Fallarino, F., & Puccetti, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.130 · Cited by 179
Increasing production of homocysteine and neopterin and degradation of tryptophan with older age
Frick, B., Schroecksnadel, K., Neurauter, G., Leblhuber, F., & Fuchs, D. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.02.007 · Cited by 178
Abrams, B. F., Duncan, D. T., & Hertz‐Picciotto, I. (1993) · PubMed · Cited by 175
Whetsell, W. O., & Schwarcz, R. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90609-5 · Cited by 175
Yang, J.-S., Xu, L.-Y., Xiao, B.-G., Hedlund, G., & Link, H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.016 · Cited by 175
Implications of Interferon-Induced Tryptophan Catabolism in Cancer, Autoimmune Diseases and Aids
Brown, R. R., Ozaki, Y., Datta, S. P., Borden, E. C., Sondel, P. M., & Malone, D. G. (1991) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-5952-4_39 · Cited by 174
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum
Rassoulpour, A., Wu, H., Ferrė, S., & Schwarcz, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03134.x · Cited by 174
Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients
Huengsberg, M., Winer, J. B., Gompels, M., Round, R., Ross, J., & Shahmanesh, M. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.4.858 · Cited by 172
Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
Widner, B., Leblhuber, F., & Fuchs, D. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200014 · Cited by 171
Brunmark, C., Runström, A., Ohlsson, L., Sparre, B., Brodin, T., Åström, M., & Hedlund, G. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00225-4 · Cited by 164
Gendelman, H. E., Zheng, J., Coulter, C. L., Ghorpade, A., Che, M., Thylin, M., Rubocki, R., Persidsky, Y., Hahn, F., Reinhard, Jr., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515693 · Cited by 162
Altered kynurenine metabolism correlates with infarct volume in stroke
Darlington, L. G., Mackay, G. M., Forrest, C. M., Stoy, N., George, C., & Stone, T. W. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05838.x · Cited by 160
Carpenedo, R., Chiarugi, A., Russi, P., Lombardi, G., Carlà, V., Pellicciari, R., Mattoli, L., & Moroni, F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90227-5 · Cited by 159
Cozzi, A., Carpenedo, R., & Moroni, F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199907000-00007 · Cited by 159
Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease
Pearson, S. J., & Reynolds, G. P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90749-w · Cited by 155
Heyes, M. P., Saito, K., Lackner, A. A., Wiley, C. A., Achim, C. L., & Markey, S. P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.881 · Cited by 152
Quinolinate neurotoxicity in cortical cell culture
Kim, J. P., & Choi, D. W. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90066-2 · Cited by 147
Fuchs, D., Möller, A. A., Reibnegger, G. J., Werner, E. R., Werner‐Felmayer, G., Dierich, M. P., & WACHTER, H. (1991) · Immunology Letters · doi:10.1016/0165-2478(91)90005-u · Cited by 145
The kynurenine pathway and inflammation in amyotrophic lateral sclerosis
Chen, Y., Stankovic, R., Cullen, K. M., Meininger, V., Garner, B., Coggan, S., Grant, R., Brew, B. J., & Guillemin, G. J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9129-7 · Cited by 141
Self-citationAβ1-42 induces production of quinolinic acid by human macrophages and microglia
Guillemin, G. J., Smythe, G. A., Veas, L. A., Takikawa, O., & Brew, B. J. (2003) · Neuroreport · doi:10.1097/00001756-200312190-00005 · Cited by 141
Self-citationPellicciari, R., Natalini, B., Costantino, G., Mahmoud, M. R., Mattoli, L., Sadeghpour, B. M., Moroni, F., Chiarugi, A., & Carpenedo, R. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00031a015 · Cited by 139
Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease
Hartai, Z., Juhász, A., Rimanóczy, Á., Janáky, T., Donkó, T., László, A., Penke, B., Tóth, G. K., Janka, Z., & Kalman, J. L. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.012 · Cited by 139
Involvement of quinolinic acid in aids dementia complex
Guillemin, G. J., Kerr, S. J., & Brew, B. J. (2005) · Neurotoxicity Research · doi:10.1007/bf03033781 · Cited by 138
Self-citationBinding of Indole Analogues to Human Serum Albumin
McMenamy, R. H. (1965) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)97049-3 · Cited by 137
Salter, M., & Pogson, C. I. (1985) · Biochemical Journal · doi:10.1042/bj2290499 · Cited by 137
Medana, I. M., Day, N. P. J., Salahifar, H., Stocker, R., Smythe, G. A., Bwanaisa, L., Njobvu, A., Kayira, K., Turner, G. D. H., Taylor, T. E., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377583 · Cited by 129
Tryptophan metabolism and oxidative stress in patients with chronic brain injury
Mackay, G., Forrest, C. M., Stoy, N. S., Christofides, J. A., Egerton, M., Stone, T. W., & Darlington, L. G. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01220.x · Cited by 128
Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid.
Melillo, G., Cox, G. W., Biragyn, A., Sheffler, L. A., & Varesio, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37169-7 · Cited by 122
Bosco, M. C., Rapisarda, A., Massazza, S., Melillo, G., Young, H. A., & Varesio, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3283 · Cited by 121
Tryptophan degradation increases with stage in patients with rheumatoid arthritis
Schroecksnadel, K., Winkler, C., Duftner, C., Wirleitner, B., Schirmer, M., & Fuchs, D. (2005) · Clinical Rheumatology · doi:10.1007/s10067-005-0056-6 · Cited by 120
Tumor immune escape mediated by indoleamine 2,3-dioxygenase
Ζαμανάκου, Μ., Germenis, A. E., & Karanikas, V. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.06.001 · Cited by 118
Dai, W., & Gupta, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45453-6 · Cited by 115
The pharmacological manipulation of glutamate receptors and neuroprotection
Stone, T. W., & Addae, J. I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01851-4 · Cited by 115
Rejdak, K., Bartosik-Psujek, H., Dobosz, B., Kocki, T., Grieb, P., Giovannoni, G., Turski, W. A., & Stelmasiak, Z. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00710-3 · Cited by 114
Acute administration of citalopram facilitates memory consolidation in healthy volunteers
Harmer, C. J., Bhagwagar, Z., Cowen, P. J., & Goodwin, G. M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1151-x · Cited by 112
Tryptophan, mood, and cognitive function
Riedel, W. J., Klaassen, T., & Schmitt, J. A. J. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00013-2 · Cited by 110
Guillemin, G. J., Smith, D. G., Kerr, S. J., Smythe, G. A., Kapoor, V., Armati, P. J., & Brew, B. J. (2000) · Redox Report · doi:10.1179/135100000101535375 · Cited by 108
Self-citationImplications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis
Guillemin, G. J., Meininger, V., & Brew, B. J. (2005) · Neurodegenerative Diseases · doi:10.1159/000089622 · Cited by 105
Self-citationChiarugi, A., Carpenedo, R., Molina, M. T., Mattoli, L., Pellicciari, R., & Moroni, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031176.x · Cited by 105
Zou, L., Abbas, N., Volkmann, I., Nennesmo, I., Levi, M., Wahren, B., Winblad, B. G., Hedlund, G., & Zhu, J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00015-1 · Cited by 101
Chiarugi, A., Cozzi, A., Ballerini, C., Massacesi, L., & Moroni, F. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00504-2 · Cited by 101
Isaji, M., Miyata, H., Ajisawa, Y., Takehana, Y., & Yoshimura, N. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701493 · Cited by 100
Effective Antiretroviral Therapy Reduces Degradation of Tryptophan in Patients with HIV-1 Infection
Zangerle, R., Widner, B., Quirchmair, G., Neurauter, G., Sarcletti, M., & Fuchs, D. (2002) · Clinical Immunology · doi:10.1006/clim.2002.5231 · Cited by 98
Prolonged Survival of a Murine Model of Cerebral Malaria by Kynurenine Pathway Inhibition
Clark, C. J., Mackay, G., Smythe, G. A., Bustamante, S., Stone, T. W., & PHILLIPS, R. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.5249-5251.2005 · Cited by 96
Sardar, A. M., Bell, J. E., & Reynolds, G. P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020932.x · Cited by 95
Morita, T., Saito, K., Takemura, M., Maekawa, N., Fujigaki, S., Fujii, H., Wada, H., Takeuchi, S., Noma, A., & Seishima, M. (2001) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563011900461 · Cited by 94
Weber, W. P., Feder‐Mengus, C., Chiarugi, A., Rosenthal, R., Reschner, A., Schumacher, R., Zajac, P., Misteli, H., Frey, D. M., Oertli, D., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200535616 · Cited by 90
Activated Immune System in Patients with Huntington's Disease
Leblhuber, F., Walli, J., Jellinger, K., Tilz, G. P., Widner, B., Laccone, F. A., & Fuchs, D. (1998) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1998.132 · Cited by 89
Nicotinylalanine Increases the Formation of Kynurenic Acid in the Brain and Antagonizes Convulsions
Russi, P., Alesiani, M., Lombardi, G., Davolio, P. L., Pellicciari, R., & Moroni, F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10097.x · Cited by 89
Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid
Harris, C. A., Miranda, A., Tanguay, J., Boegman, R. J., Beninger, R. J., & Jhamandas, K. H. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701834 · Cited by 89
Beninger, R. J., Colton, A. M., Ingles, J. L., Jhamandas, K. H., & Boegman, R. J. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90438-3 · Cited by 88
Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy
Suárez, S., Baril, L., Stankoff, B., Khellaf, M., Dubois, B., Lubetzki, C., Bricaire, F., & Hauw, J. (2001) · AIDS · doi:10.1097/00002030-200101260-00008 · Cited by 87
Tryptophan degradation in patients with gynecological cancer correlates with immune activation
Schroecksnadel, K., Winkler, C., Fuith, L. C., & Fuchs, D. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.033 · Cited by 85
KYNURENINE PATHWAY METABOLISM IN PATIENTS WITH OSTEOPOROSIS AFTER 2 YEARS OF DRUG TREATMENT
Forrest, C. M., Mackay, G., Oxford, L., Stoy, N. S., Stone, T. W., & Darlington, L. G. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04490.x · Cited by 85
Tryptophan Degradation in Patients Infected by Human Immunodeficiency Virus
Werner, E. R., FUCHS, D., Hausen, A., Jaeger, H., Reibnegger, G. J., Werner‐Felmayer, G., Dierich, M. P., & Wächter, H. (1988) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1988.369.1.337 · Cited by 82
Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites
Jhamandas, K. H., Boegman, R. J., Beninger, R. J., & Bialik, M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90826-w · Cited by 81
Fujigaki, S., Saito, K., Takemura, M., Fujii, H., Wada, H., Noma, A., & Seishima, M. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0861 · Cited by 80
Sekkaï, D., Guittet, O., Lemaire, G., Tenu, J., & Lepoivre, M. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9913 · Cited by 79
Facilitated brain uptake of 4-chlorokynurenine and conversion to 7-chlorokynurenic acid
Hokari, M., Wu, H., Schwarcz, R. M., & Smith, Q. R. (1996) · Neuroreport · doi:10.1097/00001756-199612200-00004 · Cited by 77
Flanagan, E. M., Erickson, J. B., Viveros, O. H., Chang, S. Y., & Reinhard, J. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031192.x · Cited by 77
Longitudinal study of tryptophan degradation during and after pregnancy
Schröcksnadel, K., Widner, B., Bergant, A. M., Neurauter, G., Schennach, H., Schröcksnadel, H., & Fuchs, D. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02304-4 · Cited by 76
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis
Iłżecka, J., Kocki, T., Stelmasiak, Z., & Turski, W. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00076.x · Cited by 75
Varesio, L., Clayton, M., Blasi, E., Ruffmann, R., & Radzioch, D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4265 · Cited by 72
Medana, I. M., Hien, T. T., Day, N., Phu, N. H., Mai, N. T. H., Chuong, L. V., Chau, T. T. H., Taylor, A., Salahifar, H., Stocker, R., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/339009 · Cited by 71
Control of growth by picolinic acid: Differential response of normal and transformed cells
Fernandez‐Pol, J. A., Bono, V. H., & Johnson, G. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.7.2889 · Cited by 69
Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons
Erhardt, S., Öberg, H., Mathé, J. M., & Engberg, G. (2001) · Amino Acids · doi:10.1007/s007260170032 · Cited by 69
Atlas, A., Gisslén, M., Nordin, C., Lindström, L., & Schwieler, L. (2007) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2006.02.005 · Cited by 63
Heyes, M. P., Saito, K., Milstien, S., & Schiff, S. J. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00164-w · Cited by 62
Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity
Connick, J. H., Heywood, G. C., Sills, G. J., Thompson, G., Brodie, M. J., & Stone, T. W. (1992) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(92)90017-e · Cited by 61
Giusti, R. M., Maloney, E. M., Hanchard, B., Morgan, O., Steinberg, S. M., WACHTER, H., Williams, E., Cranston, B., Fuchs, D., & Manns, A. (1996) · PubMed · Cited by 61
Pais, T. F., & Appelberg, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.389 · Cited by 60
Weight loss in patients with hematological neoplasias is associated with immune system stimulation
Denz, H. A., Orth, B., Weiss, G., Herrmann, R., Huber, P., WACHTER, H., & Fuchs, D. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00210961 · Cited by 60
Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression
Orlikov, A. B., Prakh'e, I. B., & Ryzhov, I. V. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91189-4 · Cited by 60
Kynurenine Pathway Metabolites in Cerebrospinal Fluid and Serum in Complex Partial Seizures
Heyes, M. P., Saito, K., Devinsky, O., & Nadi, N. S. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02428.x · Cited by 59
Serio, C. D., Cozzi, A., Angeli, I., Doria, L., Micucci, I., Pellerito, S., Mirone, P., Masotti, G., Moroni, F., & Tarantini, F. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-8469-y · Cited by 58
Wu, H., Lee, S.-C., & Schwarcz, R. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00024-8 · Cited by 55
Larsson, M., Hagberg, L., Norkrans, G., & Forsman, A. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490230410 · Cited by 55
Quinolinic acid production is related to macrophage tropic isolates of HIV-1
Brew, B. J., Corbeil, J., Pemberton, L. A., Evans, L. A., Saito, K., Penny, R., Cooper, D. A., & Heyes, M. P. (1995) · Journal of NeuroVirology · doi:10.3109/13550289509111026 · Cited by 53
Fernandez‐Pol, J. A., Klos, D. J., & Hamilton, P. D. (2001) · PubMed · Cited by 51
Moffett, J., Els, T., Espey, M., Walter, S. A., Streit, W. J., & Namboodiri, M. A. A. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6365 · Cited by 50
Foster, A. C., Willis, C. L., & Tridgett, R. (1990) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1990.tb00418.x · Cited by 50
Moroni, F., Cozzi, A., Carpendo, R., Cipriani, G., Veneroni, O., & Izzo, E. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.10.019 · Cited by 47
Kynurenic acid metabolism in the brain of HIV-1 infected patients
Baran, H., Hainfellner, J. A., Kepplinger, B., Mazal, P. R., Schmid, H., & Budka, H. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070026 · Cited by 47
Wu, H., Salituro, F. G., & Schwarcz, R. M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00829-1 · Cited by 46
Moffett, J., Espey, M., Gaudet, S. J., & Namboodiri, A. (1993) · Brain Research · doi:10.1016/0006-8993(93)91450-7 · Cited by 43
Murray, M. F., Langan, M. J., & MacGregor, R. R. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00568-8 · Cited by 42
Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes
Murr, C., Gerlach, D., Widner, B., et al. (2001) · Medical Microbiology and Immunology · doi:10.1007/s430-001-8023-3 · Cited by 41
Iwagaki, H., HIZUTA, A., Tanaka, N., & Orita, K. (1995) · Immunological Investigations · doi:10.3109/08820139509066843 · Cited by 41
Cockhill, J., Jhamandas, K. H., Boegman, R. J., & Beninger, R. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)90852-z · Cited by 40
Chiarugi, A., & Moroni, F. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00048-9 · Cited by 40
Gisslén, M., Larsson, M., Norkrans, G., Fuchs, D., WACHTER, H., & Hagberg, L. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.947 · Cited by 38
Mass spectrometric detection of quinolinic acid in microdissected Alzheimer's disease plaques
Guillemin, G. J., Brew, B. J., Noonan, C. E., Knight, T. G., Smythe, G. A., & Cullen, K. M. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.012 · Cited by 36
Self-citationLook, M. P., Altfeld, M. A., Kreuzer, K., Riezler, R., Stabler, S. P., Allen, R. H., Sauerbruch, T., & Rockstroh, J. K. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/08892220050116989 · Cited by 33
Demitrack, M. A., Heyes, M. P., Altemus, M. M., Pigott, T. A., & Gold, P. W. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00173-z · Cited by 33
Increased plasma free tryptophan levels in human cancer: a tumor related effect?
Cascino, A., Cangiano, C., Ceci, F., Franchi, F., Mineo, T. C., Mulieri, M., Muscaritoli, M., & Fanelli, F. R. (1991) · PubMed · Cited by 33
Blasi, E., Mazzolla, R., Pitzurra, L., Barluzzi, R., & Bistoni, F. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2422 · Cited by 32
Espey, M., Tang, Y., Morse, H., Moffett, J., & Namboodiri, M. A. A. (1996) · AIDS (London) · doi:10.1097/00002030-199602000-00004 · Cited by 32
Characterization of the kynurenine pathway in human oligodendrocytes
Lim, C. K., Smythe, G. A., Stocker, R., Brew, B. J., & Guillemin, G. J. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.011 · Cited by 32
Self-citationPicolinic acid modulates kainic acid-evoked glutamate release from the striatum in vitro
Vrooman, L. M., Jhamandas, K. H., Boegman, R. J., & Beninger, R. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)90320-m · Cited by 31
Kynurenic acid actions in brain and periphery
Moroni, F., Fossati, S., Chiarugi, A., & Cozzi, A. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.016 · Cited by 27
7‐Chlorokynurenate Blocks NMDA Receptor‐Mediated Neurotoxicity in Murine Cortical Culture
Hartley, D. M., Monyer, H., Colamarino, S. A., & Choi, D. W. (1990) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1990.tb00420.x · Cited by 26
Role of zinc in blockade of excitotoxic action of quinolinic acid by picolinic acid
Jhamandas, K. H., Boegman, R. J., Beninger, R. J., & Flesher, S. (1998) · Amino Acids · doi:10.1007/bf01345272 · Cited by 25
Studies on kynurenine in human cerebrospinal fluid: Lowered levels in epilepsy
Young, S. N., Joseph, M. H., & Gauthier, S. G. (1983) · Journal of Neural Transmission · doi:10.1007/bf01252805 · Cited by 25
Baig, S., Halawa, I., & Qureshi, G. A. (1991) · Biomedical Chromatography · doi:10.1002/bmc.1130050304 · Cited by 20
López, A. S., Alegre, E., Díaz‐Lagares, Á., et al. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.01.001 · Cited by 19
Rapisarda, A., Pastorino, S., Massazza, S., Varesio, L., & Bosco, M. C. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(03)00008-x · Cited by 19
Rao, T. S., Gray, N. M., Dappen, M. S., et al. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90094-j · Cited by 18
Ting, K.-K., Brew, B., & Guillemin, G. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.010 · Cited by 11
Self-citation
Cited by
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382
Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects
Badawy, A. A.-B. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691938 · Cited by 1,158
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
Munn, D. H., & Mellor, A. L. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.001 · Cited by 1,037
Quinolinic acid, the inescapable neurotoxin
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08485.x · Cited by 595
Self-citation
Metadata
- Authors
- Chen, Y., & Guillemin, G. J.
- Venue
- International Journal of Tryptophan Research
- Publisher
- SAGE Publications
- Published
- 2009-01
- Volume
- 2
- Pages
- 1-19
- ISSN
- 1178-6469 (ISSN-L)
- OpenAlex
- W1571431689
- Cited by
- 628
- References
- 185
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.